EVALUATION
OF THYROID FUNCTION MARKERS IN TYPE 2 DIABETIC PATIENTS IN RELATION TO INSULIN
RESISTANCE
Pshtiwan Khdir Othman a*,
Ismail Salih Kakey a
Department of biology, Faculty of science &
Health, Koya University, Koya,
Kurdistan Region – Iraq
Email: pshtiwan1986xdr@gmail.com esmail.kakey@koyauniversity.org
Received: 14
Nov., 2022 / Accepted: 12 Feb., 2023 / Published: 29 May, 2023 https://doi.org/10.25271/sjuoz.2023.11.2.1063
ABSTRACT: Diabetes mellitus (DM)
and thyroid disorders are both caused by endocrine abnormalities, and both have
been shown to have a reciprocal influence and frequently
coexist. Hence,
the current study aims to detect the thyroid functions markers among patients
with Type 2 diabetes (T2DM). In this
research study, 90 enrolled participants aged 40 to 60 years were taken as
samples for the study. There were 66 with T2DM and 24 who were non diabetic
healthy individual. All individuals were investigated in terms of age, gender,
diabetes duration, glycemic control (HbA1c), fasting blood glucose (FBG),
diabetic complications, Body mass index (BMI), waist circumference (WC),
and family history of DM. Samples were to assess serum thyroid hormones (TSH, FT3
and FT4), HbA1c, FBG, and insulin levels. The study's findings showed higher glucose
incidence, hyperinsulinemia and higher insulin resistance (IR) in diabetic patients.
Additionally, it has been noted that T2DM patients have low TSH concentrations
and elevated blood concentrations of FT4 and FT3 than controls. Moreover, there was a highly significant correlation
between serum FT4 and FT3 with values of FBG, insulin and IR. Also, a significant association between WC with insulin and
Homa – Ir was noted. In conclusion, the diabetic
patients showed significant relations with thyroid functions status.
KEYWORDS: Type 2 Diabetes, Insulin Resistance, Thyroid Related Hormones, HOMA-IR, HbA1c.
1.
INTRODUCTION
Diabetes
and thyroid problems are the two most frequent endocrine disorders caused by
endocrine abnormalities, and both have been found to have a mutual impact on
each other. DM and thyroid problems frequently coexist, often noticed in
clinical practice; they have a close connection and bidirectional influence
upon each other (Li et al., 2022). Thyroid disorders are more likely to emerge in T2DM
over time, with rates ranging from 9.9% to 48%. Furthermore, investigations
have revealed a significant frequency of thyroid issue in the 13.4% diabetic
population, with a larger prevalence (31.4%) among females with T2DM than males
with T2DM (6.9%) (Hussein & AbdElmageed, 2021). According to
a study, thyroid, kidney, and pancreas are all functionally associated to
diabetes (Khidir & Kakey, 2013).
Recent
studies have demonstrated that people with diabetes mellitus also have greater
rates of thyroid disorders, and vice versa (Shah et al.). Thyroxine (T4) is not properly converted to
triiodothyronine (T3) in peripheral tissues in
T2DM, which also lowers the levels of thyroid-stimulating hormone (Kalra et al., 2021). Researchers have shown that carbohydrate metabolism
and pancreatic functions are regulated by thyroid hormones (THs) (Shehzad et al., 2022). (T3) regulates cell activity physiologically by
influencing how much glucose is taken in by pancreatic cells, which in turn
regulates the release of insulin. Additionally, THs influence the metabolism of
glucose in tissues that respond to insulin such as liver, adipose tissue and
skeletal muscle (Al-bayati &
Al-Khateeb, 2021). Besides above findings also a study reported high
TSH level and low free thyroxine (FT4) level in diabetic patients, with a
positive impact of thyroid hormones on hyperglycemia and insulin resistance (Rong et al., 2021). Thyroid hormones (FT4) and (FT3) have been shown to
have both agonistic and antagonistic effects on insulin in various organs (Spira et al., 2022). Decreased tissue response to insulin
is the definition of insulin resistance. Hyperinsulinemia develops in the body
tissues due to how tissues respond to insulin (Demiral Sezer &
Erdoğan Yücel, 2021). Based on fasting plasma glucose (FPG)
and insulin, the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
method is used for evaluating function of Pancreatic beta
cell (β-cells) and IR. The (HOMA-IR) is a formula which estimates
insulin sensitivity using FPG and insulin serum concentrations. Therefore, it frequently
used to diagnose insulin resistance and metabolic state (Ha et al., 2021). Obesity, particularly abdominal obesity, may be
linked to T2DM via increasing IR. Obesity may be measured using the (BMI), and
abdominal obesity can be examined by measuring the WC (Alkhalidy et al., 2021). The current study was done to investigate the
functional association between T2DM and thyroid disorders.
2.
MATERIALS AND METHODOLOGY
A
case control design was used in this study to investigate thyroid hormones and
insulin resistance in T2DM patients. The study includes 66 diabetic patients
(33 males and 33 females) at ages range from (40-60) years, and are on the
metformin treatment. 24 subjects (12
males and 12 females) of age and sex matched with individuals free from signs
and symptoms of DM disease were included as control group. The personal
information and history of both patients and healthy individuals were recorded
in a questionnaire. The interview concluded, participants information such as the
patient’s name, age, gender, address, duration of
diabetes, diabetes complications, BMI, occupation, marital status, waist
circumference and family history for DM.
The waist circumference is used to measure
central obesity, while BMI is used to establish if a person is overweight or
obese. BMI was determined using the conventional method as follows: BMI =
weight (in kg) / height2 (in m2)(Strings et al., 2023).
For biochemical analysis, an overnight
fasting blood samples (10-12 hrs.) were collected from the cases and controls
attending the shahedan Qaladze
teaching hospital in the Iraqi Kurdistan region from October 2021 to January
2022 by using disposable syringes and needles about 10 ml of blood was taken
from each subject. Blood samples were put in two different types of tubes, one
of them is Lavender Top Tube contains EDTA as the anticoagulant and is used for
HbA1c test (Abdullateef &
Saleh, 2021). The other part was a 5ml of blood used for serum separation by
centrifugation. After that, serum samples were obtained, then serum transferred
into Eppendorf and tubes stored at deep-freezing point of (-20 °C) for
biochemical analysis.
The measurement
of serum fasting glucose and Hba1c was performed using Giesse
diagnostics kit (Italy) on Geno TEK Chemistry analyzer 150 (Aflo
Company - USA), Thyroid stimulating hormone (TSH), free triiodothyronine (FT3),
and free thyroxine (FT4) insulin levels were measured using the Roche
Diagnostic GmbH Kit (Germany) by Cobas e 411 Roche Company (Germany). (HOMA-IR) is a widely used method for measuring insulin
resistance. It was derived from the following formula: HOMA-IR = [fasting
glucose] (mg/dl) × [fasting insulin] (μU/ml)/405
(Abdullah & Salih,
2023).
.
Statistical Analyses
The statistical analysis was done using
Prism 8.0.1., SPSS version 24.0 and Microsoft excel program (2019) for
Independent Samples T test and correlation coefficient calculations. The
variables were summarized as mean and standard error. Probability (p) value <
0.05 was accepted as statistically significant) * p < 0.05, ** p <
0.01, *** p < 0.001, NS not significant).
In the current study, the glucose incidence analysis revealed, the
levels of FPG, Hba1c, and HOMA-IR in the diabetes group were significantly
higher than in the healthy control group. In addition, serum insulin levels in
DM patients were higher but not different statistically when compared with
control group (Male and female), as illustrated in the table (1).
Table 1.Glucose incidence parameters
in diabetic patients compared to controls
Sex |
Diabetic group |
Normal group |
P value |
|
Fasting glucose mg/dL |
male |
174.8 ± 10.17 |
98.85 ± 2.9 |
0.001 *** |
female |
207.1 ± 12.31 |
98.17 ± 2.631 |
0.001 *** |
|
Hba1c (%) |
male |
8.841 ± 0.324 |
5.274 ± 0.071 |
0.001 *** |
female |
8.491 ± 0.224 |
5.465 ± 0.09 |
0.001 *** |
|
Insulin uU/ml |
male |
12.07 ± 1.160 |
9.392 ±0.9254 |
0.068 NS |
female |
13.63 ±1.153 |
9.761 ± 1.261 |
0.223 NS |
|
HOMA-IR |
male |
4.571 ± 0.381 |
3.139 ± 0.394 |
0.0318 * |
female |
6.018 ± 0.590 |
2.572 ± 0.373 |
0.001 *** |
The
thyroid functions test parameters of the studied participants are shown in table (2), the levels of serum T3 and T4
were significantly high while serum TSH levels was significantly low in T2D
group, compared to control group. The study of the thyroid status showed, that there is no
significant difference in Ft3/Ft4 ratio levels among females in the T2D group
compared to the control group.
Table 2. Thyroid functions test parameters in diabetic patients
compared to controls
sex |
Diabetic group |
Normal group |
P value |
|
TSH ng\ml |
male |
1.499 ± 0.160 |
2.124 ± 0.165 |
0.060 * |
female |
1.545 ± 0.208 |
2.365 ± 0.278 |
0.039 * |
|
FT4 pg/ml |
male |
18.03 ± 0.459 |
15.76 ± 0.380 |
0.0052 ** |
female |
17.37 ± 0.472 |
14.38 ± 0.659 |
0.0017 ** |
|
FT3 pg/ml |
male |
5.439 ± 0.096 |
5.049 ± 0.103 |
0.0263 * |
female |
5.688 ± 0.181 |
4.647 ± 0.144 |
0.0022 ** |
|
Ft3/Ft4 Ratio |
male |
0.2824 ± 0.006 |
0.322 ± 0.011 |
0.0025 ** |
female |
0.3264 ± 0.011 |
0.317 ± 0.010 |
0.6739 NS |
As
seen in Table (3) and figure (1), in diabetic patients, there were highly
significant negative correlation between serum Ft4 and values of FPG, insulin,
and HOMA-IR.
Table 3.Correlation between serum free thyroxine levels with fasting
glucose, insulin and Homeostatic Model Assessment for Insulin Resistance
Parameters |
Patients group |
|
R |
P values |
|
-0.439 |
0.0004 *** |
|
-0.418 |
0.0006 *** |
|
Ft4 and HOMA-IR |
-0.445 |
0.0002 *** |
The
data analysis of the current results of correlation evaluation showed negative
correlations between Ft3 and HOMA-IR, FPG and insulin. However,
there were positive associations between Ft3 and Hba1c.
HOMA-IR and the Ft3 / Ft4 ratio also have a significant and positive correlation
(Table 4).
Table 4.Correlation between serum free triiodothyronine levels with Homeostatic Model Assessment for Insulin Resistance, fasting glucose, insulin, and hemoglobin
A1C and free triiodothyronine / free thyroxine
ratio with Homeostatic Model Assessment for Insulin Resistance
Parameters |
Patients group |
|
R |
P values |
|
Ft3 and fasting glucose |
-0.459 |
0.0003 *** |
Ft3 and Insulin |
-0.337 |
0.0083 ** |
Ft3 and HOMA-IR |
-0.255 |
0.046 * |
0.351 |
0.0055 ** |
|
Ft3 and Hba1c |
0.347 |
0.0065 ** |
Figure 1: Correlation between A. free thyroxine levels with
Fasting glucose B. free thyroxine levels with Insulin C. free thyroxine
levels with Homeostatic Model Assessment for Insulin Resistance
In this study, as showed
in Table (5) there were noted a significant association
between WC with insulin and Homa Ir.
Table 5.Correlations between waist circumference with insulin and Homeostatic
Model Assessment for Insulin Resistance.
Parameters |
Patients group |
|
R |
P values |
|
WC
and insulin |
0.588 |
0.0001 *** |
WC
and Homa Ir |
0.565 |
0.0001 *** |
Figure 2:Correlation between A. free triiodothyronine with fasting glucose B.
free triiodothyronine with Insulin C. free triiodothyronine with Homeostatic Model
Assessment for Insulin Resistance D. free triiodothyronine with hemoglobin A1C.
Figure 3: Correlations between A. waist
circumference with insulin B. waist circumference with Homeostatic
Model Assessment for Insulin Resistance.
Fasting glucose has a significant positive
correlation with Hba1c and insulin, as illustrated in table (6). However, as
shown in the table (7), HbA1c and fasting glucose are considerably and strongly
linked with the duration of diabetes.
Table 6. Correlations between fasting glucose with hemoglobin A1C and
insulin.
Parameters |
Patients group |
|
R |
P values |
|
Fasting glucose and Hba1c |
0.4947 |
0.0001*** |
Fasting
glucose and insulin |
0.357 |
0.0051 ** |
Table 7. Correlations between duration of diabetes with hemoglobin A1C
and fasting glucose.
Parameters |
Patients group |
|
R |
P values |
|
duration
of diabetes and Hba1c |
0.472 |
0.0001 *** |
duration
of diabetes and fasting |
0.493 |
0.0001 *** |
Figure 4: Correlations between A. fasting glucose with Hba1c B. fasting glucose with insulin
Figure 5: Correlations between A. duration of diabetes with hemoglobin
A1C B. duration of diabetes with fasting glucose.
This study's
findings revealed that hyperinsulinemia and insulin resistance is higher in
diabetic patients. This result was in agreement with previous study
reported that insulin resistance precedes the development of hyperinsulinemia (Nolan & Prentki, 2019). Insulin
resistance, a condition in which the body does not respond well to the effects
of insulin as it should, is linked to hyperinsulinemia. In that case, the
pancreas produces more insulin in an effort to overcome the resistance, which
raises the blood levels of insulin (Janssen, 2021). On the
other hand, insulin resistance contributes significantly to the development of thyroid disorders in T2DM patients
(Mehalingam et
al., 2020). The effects
of thyroid hormone (THs) on glucose homeostasis have long been recognized. It
has been linked to β-cells formation and has been shown to alter glucose
metabolism via several organs including the liver, gastrointestinal tract,
pancreas, adipose tissue, skeletal muscles, and the central nervous system (Eom et al.,
2022). The thyroid
hormones act as insulin agonists and antagonists, respectively, to maintain a
delicate equilibrium of glucose homeostasis. This equilibrium can be upset by
hypothyroidism, which can also change glucose metabolism and result in insulin
resistance (Vyakaranam et
al., 2014).The
majority of obese people with insulin resistance have metabolic liver disease, due
to alterations in lipid and glucose metabolism brought on by hyperinsulinemia,
which may affect hepatic T4 to T3 conversion and the feedback effect of free
hormone fractions on TSH synthesis (Racataianu et
al., 2017). The
current investigation found that serum TSH level was lower.
In addition,
patients with T2DM had significantly greater serum FT4 and FT3 levels than
controls. Hyperthyroidism can be overt or subclinical. Overt hyperthyroidism is
defined by low (TSH) concentrations and increased blood concentrations of
thyroid hormones T4, T3 or both. Additionally, subclinical hyperthyroidism is
defined by normal T4 and T3 levels but low blood TSH levels (De Leo et al.,
2016). The
findings of the current research detected a significantly negative association
of FT4 with variables related to glucose homeostasis in diabetic male and
female patients. Moreover, it
has been noted that T2DM patients have higher rates of hyperthyroidism than control, our findings are in agreement with previous studies (US & Monika, 2022). Condorelli et
al. (2022) showed that
metformin therapy can dramatically lower TSH and raise FT4 and FT3 blood levels
in those with healthy thyroid function. Metformin's ability to reduce TSH has
been attributed to a number of molecular processes. Some researchers have
proposed changes in thyroid hormone receptor affinity or expression, elevated
central dopaminergic tone, and effects on TSH control as potential explanatory
mechanisms (Cannarella et
al., 2021). Another
significant finding from the study was that, fasting glucose, fasting insulin
levels and HOMA-IR were decreased with increasing FT4. This study supports
evidence from previous observations (Ha et al.,
2021).In addition
, the current study found that FT3 was adversely linked with fasting glucose,
insulin secretion, and IR in T2DM patients. Shi et al. (2021) reported the
connection between FT3 and adverse metabolic conditions such obesity, mixed
hyperlipidemia, and hyperglycemia. Moreover, it was noted in the study that
high levels of FT3 were linked to the development of insulin resistance and
that low levels of FT3 were directly linked to a reduction in HOMA-IR.
Previously, it was discovered that high serum FT4 levels in individuals with T2DM
were connected with glucose homeostasis parameters (Spira et al.,
2022). The
correlations finding of glycemic status parameters, IR and thyroid hormones
with BMI, and WC in T2DM patients. The results of
this study show a correlation between greater BMI and higher HbA1c.This pattern
of the association of T2DM and thyroid function may be caused by effect of BMI
rising on HbA1C as previously mentioned
(Boye et al.,
2021; Skogberg et al., 2019). Obesity
causes cells in the body to become less responsive to insulin generated by the
pancreas, which can lead to insulin resistance. This indicates that the body's
insulin is not efficiently lowering its sugar levels. Obesity, on the other
hand, impairs adipose tissue function, resulting in decreased adipokine release
into the circulation. Excess fat cells, over time, will cause fat cells to
become resistant to insulin's antilipolytic actions, resulting in an increase
in the process of lipolysis and free fatty acids in plasma. Free fatty acids
boost gluconeogenesis resistance, which then triggers insulin in the liver and
muscles (Sarnings et al.,
2022). However,
in patients with type 2 diabetes mellitus, higher BMI and WC were linked to
increased insulin resistance and lower insulin sensitivity (Deusdará et al.,
2022; Zhao et al., 2017). The
relationship and interaction between obesity and T2DM are mediated by a number
of mechanisms, including increased lipolysis, higher levels of free fatty acid
release from adipose tissue, decreased glucose uptake, and the increased
secretion of pro-inflammatory signals, which may impair insulin sensitivity.
Alterations in the release of adipokines and pro-inflammatory cytokines by
adipose tissue have the potential to directly affect insulin signaling or to
activate pro-inflammatory pathways in target tissues, which causes local and
subsequently systemic insulin resistance (Blüher & Stumvoll, 2020).
We observed that the levels of FPG and Hba1c, were considerably higher
in the diabetic group as compared to normal participants, this observation
agrees with the results of various earlier researches. Studies of Shivaprasad et
al. (2019), in
diabetic patients showed significant correlation between HbA1c and
duration of diabetes. The results
of this study were similar to a previous study were done by Widyaningsih and Ahsani (2021). The
development of diabetes from normal glucose tolerance is characterized by
decreases in β-cells mass that result in reduced β-cells function.
The resulting glucotoxicity may be a recognized factor for the stimulation of
apoptosis, leading to proliferative abnormalities in β-cells. Therefore,
it is possible that β-cells function might be compromised by having
diabetes for a prolonged period of time, especially if glycemic control was
inadequate (Hayashino et
al., 2017). Patients
with diabetes for an extended period of time (more than 7 years) were more
likely to have poor glycemic control. Recent research found that people with
diabetes for more than ten years were more likely to have poor glycemic control
than those with diabetes for three years. This might be attributed to ß-cell
progressive impairment of insulin secretion over time, a rise in insulin
resistance, and an abrupt drop in insulin secretion (Mamo et al.,
2019).
5.
CONCLUSION
In the light of the
results of this study which has been conducted for the first time in Qaladze City, we have reached the conclusion that the
physiological correlations of hyperglycemic incidence with thyroid functions
markers, and a significant contribution of insulin resistance development with
developments of thyroid problems in people with type 2 diabetes.
6.
Ethical Clearance
The project was approved
by the local ethical committee at Koya University, Faculty of Health & Science. The project has also received approval from
the Ministry of Health of the Kurdistan Regional Government to be conducted in
the hospitals. Patients were asked to provide their
informed permission. Data anonymity was protected at all levels of data
processing.
Abdullah,
B. I., & Salih, S. F. (2023). Lipoprotein (a) Level Among Patients with
Type 2 Diabetes Mellitus and Prediabetes in Comparison with Healthy Controls. Science Journal of University of Zakho, 11(1),
30-36.
Abdullateef,
A. H., & Saleh, B. O. (2021). Evaluation of glycated hemoglobin results in
different anticoagulant materials and methods. Medical Journal of Babylon, 18(4), 351-351.
Al-bayati,
A., & Al-Khateeb, S. (2021). The effects of thyroid hormones and their
abnormalities on intestinal and hepatic glucose metabolism. J Sch. Int. J. Biochem, 4, 26-36.
Alkhalidy,
H., Orabi, A., Alnaser, K., Al-Shami, I., Alzboun, T., Obeidat, M. D., &
Liu, D. (2021). Obesity Measures as Predictors of Type 2 Diabetes and
Cardiovascular Diseases among the Jordanian Population: A Cross-Sectional
Study. J International journal of
environmental research public health, 18(22), 12187.
Blüher,
M., & Stumvoll, M. (2020). Diabetes and Obesity. In Diabetes Complications, Comorbidities and Related Disorders (pp.
1-49): Springer.
Boye, K.
S., Lage, M. J., Shinde, S., Thieu, V., & Bae, J. P. (2021). Trends in
HbA1c and body mass index among individuals with type 2 diabetes: evidence from
a US database 2012–2019. Diabetes
Therapy, 12(7), 2077-2087.
Cannarella,
R., Condorelli, R., Barbagallo, F., Aversa, A., Calogero, A., & La Vignera,
S. (2021). TSH lowering effects of metformin: a possible mechanism of action. J Journal of Endocrinological Investigation,
44(7), 1547-1550.
Condorelli,
R. A., Cannarella, R., Aversa, A., Basile, L., Avola, O., Calogero, A. E.,
& La Vignera, S. (2022). Effects of Slow-Acting Metformin Treatment on the
Hormonal and Morphological Thyroid Profile in Patients with Insulin Resistance.
J Pharmaceutics, 14(10), 1987.
De Leo,
S., Lee, S. Y., & Braverman, L. E. (2016). Hyperthyroidism. Lancet, 388(10047), 906-918.
doi:10.1016/s0140-6736(16)00278-6
Demiral
Sezer, S., & Erdoğan Yücel, E. (2021). Does insulin resistance trigger
thyroid nodule? J Internal Emergency
Medicine, 16(8), 2105-2108.
Deusdará,
R., de Moura Souza, A., & Szklo, M. (2022). Association between Obesity,
Overweight, Elevated Waist Circumference, and Insulin Resistance Markers among
Brazilian Adolescent Students. J
Nutrients, 14(17), 3487.
Eom, Y.
S., Wilson, J. R., & Bernet, V. J. (2022). Links between thyroid disorders
and glucose homeostasis. Diabetes &
Metabolism Journal, 46(2), 239-256. doi:https://doi.org/10.4093/dmj.2022.0013
Ha, J.,
Lee, J., Lim, D.-J., Lee, J.-M., Chang, S.-A., Kang, M.-I., & Kim, M.-H.
(2021). Association of serum free thyroxine and glucose homeostasis: Korea
National Health and Nutrition Examination Survey. The Korean Journal of Internal Medicine, 36(Suppl 1), S170.
Hayashino,
Y., Izumi, K., Okamura, S., Nishimura, R., Origasa, H., Tajima, N., &
Group, J. S. (2017). Duration of diabetes and types of diabetes therapy in
Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its
Prevention prospective study 3 (JDCP study 3). Journal of diabetes investigation, 8(2), 243-249.
Hussein,
S. M. M., & AbdElmageed, R. M. (2021). The relationship between type 2
diabetes mellitus and related thyroid diseases. Cureus, 13(12).
Janssen,
J. A. (2021). Hyperinsulinemia and its pivotal role in aging, obesity, type 2
diabetes, cardiovascular disease and cancer. International Journal of Molecular Sciences, 22(15), 7797.
Kalra,
S., Aggarwal, S., & Khandelwal, D. (2021). Thyroid dysfunction and
dysmetabolic syndrome: the need for enhanced thyrovigilance strategies. J International journal of endocrinology,
2021.
Khidir,
K. A., & Kakey, S. R. K. I. S. (2013). Role of green tea extract in
reducing pathological changes of induced diabetes mellitus in rats. J Rafidain Journal of Science, 24(7),
1-12.
Li, Y.,
Yi, M., Deng, X., Li, W., Chen, Y., & Zhang, X. (2022). Evaluation of the
Thyroid Characteristics and Correlated Factors in Hospitalized Patients with
Newly Diagnosed Type 2 Diabetes. J
Diabetes, Metabolic Syndrome Obesity: Targets Therapy, 15, 873.
Mamo,
Y., Bekele, F., Nigussie, T., & Zewudie, A. (2019). Determinants of poor
glycemic control among adult patients with type 2 diabetes mellitus in Jimma
University Medical Center, Jimma zone, south west Ethiopia: a case control
study. BMC endocrine disorders, 19,
1-11.
Mehalingam,
V., Sahoo, J., Bobby, Z., & Vinod, K. V. (2020). Thyroid dysfunction in
patients with type 2 diabetes mellitus and its association with diabetic
complications. J Journal of Family
Medicine Primary Care, 9(8), 4277.
Nolan,
C. J., & Prentki, M. (2019). Insulin resistance and insulin hypersecretion
in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework
shift. Diabetes and Vascular Disease
Research, 16(2), 118-127.
Racataianu,
N., Leach, N., Bondor, C. I., Marza, S., Moga, D., Valea, A., & Ghervan, C.
(2017). Thyroid disorders in obese patients. Does insulin resistance make a
difference? J ARCHIVES OF ENDOCRINOLOGY
METABOLISM, 61(6), 575-583.
Rong,
F., Dai, H., Wu, Y., Li, J., Liu, G., Chen, H., & Zhang, X. (2021).
Association between thyroid dysfunction and type 2 diabetes: a meta-analysis of
prospective observational studies. J BMC
medicine, 19(1), 1-13.
Sarnings,
W., Aman, A. M., Rasyid, H., Bakri, S., Sanusi, H., As Daud, N. m., &
Zainuddin, A. A. (2022). Obesity
Measurement Index Is Associated With Hemoglobin A1c Level in Young Adult
Without Diabetes: A Single-Center Cross-Sectional Study.
Shah, P.
S., Chaudhary, R., Desai, G. J., & Goswami, D. N. A Study of Thyroid
Dysfunction in Patients of Type 2 Diabetes Mellitus: A Case Control Study.
Shehzad,
S., Naeem, M., Khan, R., Khan, R. A., Rehman, S., & Naz, R. (2022).
Diabetes: Insights into Thyroid Hormones. J
Pakistan Journal of Medical Health Sciences, 16(06), 828-828.
Shi, R.,
Lin, C., Hong, Y., Xia, X., Chen, Y., Li, S., & Xiu, L. (2021). Free
triiodothyronine is independently associated with nonalcoholic fatty liver
disease in hospitalized type 2 diabetes mellitus patients. BioMed Research International, 2021.
Shivaprasad,
C., Anish, K., Aiswarya, Y., Atluri, S., Rakesh, B., Anupam, B., & Amit, G.
(2019). A comparative study of the clinical profile of fibrocalculous
pancreatic diabetes and type 2 diabetes mellitus. J Diabetes Metabolic Syndrome: Clinical Research Reviews, 13(2),
1511-1516.
Skogberg,
N., Laatikainen, T., Lilja, E., Lundqvist, A., Härkänen, T., & Koponen, P.
(2019). The association between anthropometric measures and glycated
haemoglobin (HbA1c) is different in Russian, Somali and Kurdish origin migrants
compared with the general population in Finland: a cross-sectional
population-based study. BMC public health,
19(1), 1-12.
Spira,
D., Buchmann, N., Dörr, M., Markus, M. R., Nauck, M., Schipf, S., . . . Völzke,
H. (2022). Association of thyroid function with insulin resistance: data from
two population-based studies. European
Thyroid Journal, 11(2).
Strings,
S., Wells, C., Bell, C., & Tomiyama, A. (2023). The association of body
mass index and odds of type 2 diabetes mellitus varies by race/ethnicity. Public Health, 215, 27-30.
US, D.,
& Monika, M. (2022). The profile of thyroid disorders in patients with type
2 diabetes mellitus patients above age of 40 years. J European Journal of Molecular Clinical Medicine, 9(7), 414-418.
Vyakaranam,
S., Vanaparthy, S., Nori, S., Palarapu, S., & Bhongir, A. V. (2014). Study
of insulin resistance in subclinical hypothyroidism. International journal of health sciences and research, 4(9), 147.
Widyaningsih,
N., & Ahsani, D. N. (2021). Correlation
of Age, Duration of Diabetes Mellitus, HbA1c Levels, and Erectile Dysfunctions
in Type II Diabetes Mellitus. Paper presented at the 4th International
Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN
2020).
Zhao,
Q., Laukkanen, J. A., Li, Q., & Li, G. (2017). Body mass index is
associated with type 2 diabetes mellitus in Chinese elderly. J Clinical interventions in aging, 12,
745.